Incidence of solid tumors in polycythemia vera treated with phlebotomy with or without hydroxyurea: ECLAP follow-up data

被引：18
|
作者：
Ghirardi, Arianna [1 ]
Carobbio, Alessandra [1 ]
Masciulli, Arianna [1 ]
Barbui, Tiziano [1 ]
机构：
[1] IFROM Res Fdn, Papa Giovanni Hosp 23, Bergamo, Italy
来源：
BLOOD CANCER JOURNAL | 2018年 / 8卷
关键词：
MYELOPROLIFERATIVE NEOPLASMS; RISK;
D O I：
10.1038/s41408-017-0038-3
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [31] THE INCIDENCE OF MANIFESTED STRABISMUS IN CONGENITAL HYPOTHYROIDISM TREATED EARLY - FOLLOW-UP EXPERIENCE
    SANTILLO, C
    TORCE, MC
    MARINELLI, E
    COSTA, P
    NATOLI, G
    MOSCHINI, L
    RIVISTA ITALIANA DI PEDIATRIA-ITALIAN JOURNAL OF PEDIATRICS, 1985, 11 (05): : 632 - 632
  • [32] Estimating the standardized incidence ratio (SIR) with incomplete follow-up data
    Heiko Becher
    Volker Winkler
    BMC Medical Research Methodology, 17
  • [33] Estimating the standardized incidence ratio (SIR) with incomplete follow-up data
    Becher, Heiko
    Winkler, Volker
    BMC MEDICAL RESEARCH METHODOLOGY, 2017, 17
  • [34] Extended follow-up of small melanocytic choroidal tumors treated with transpupillary thermotherapy
    Win, PH
    Robertson, DM
    Buettner, H
    McCannel, CA
    Bennett, SR
    ARCHIVES OF OPHTHALMOLOGY, 2006, 124 (04) : 503 - 506
  • [35] Epileptic seizures during follow-up of patients treated for primary brain tumors
    Hildebrand, J
    Lecaille, C
    Perennes, J
    Delattre, JY
    NEUROLOGY, 2005, 65 (02) : 212 - 215
  • [36] JAK2V617F Complete Molecular Remission in Long-Term Follow-up of Patients with Polycythemia Vera and Essential Thrombocythemia Treated with Ruxolitinib
    Pieri, Lisa
    Pancrazzi, Alessandro
    Pacilli, Annalisa
    Rabuzzi, Claudia
    Rotunno, Giada
    Guglielmelli, Paola
    Fjerza, Rajmonda
    Paoli, Chiara
    Fanelli, Tiziana
    Bosi, Alberto
    Verstovsek, Srdan
    Vannucchi, Alessandro Maria
    BLOOD, 2014, 124 (21)
  • [37] Ruxolitinib versus best available therapy in patients with polycythemia vera: 80-week follow-up from the RESPONSE trial
    Verstovsek, Srdan
    Vannucchi, Alessandro M.
    Griesshammer, Martin
    Masszi, Tamas
    Durrant, Simon
    Passamonti, Francesco
    Harrison, Claire N.
    Pane, Fabrizio
    Zachee, Pierre
    Kirito, Keita
    Besses, Carlos
    Hino, Masayuki
    Moiraghi, Beatriz
    Miller, Carole B.
    Cazzola, Mario
    Rosti, Vittorio
    Blau, Igor
    Mesa, Ruben
    Jones, Mark M.
    Zhen, Huiling
    Li, Jingjin
    Francillard, Nathalie
    Habr, Dany
    Kiladjian, Jean-Jacques
    HAEMATOLOGICA, 2016, 101 (07) : 821 - 829
  • [38] A 17-YEAR FOLLOW-UP STUDY ON THE CLINICAL AND HEMATOLOGIC RESULTS OF TOTAL THYROIDECTOMY IN A CASE OF POLYCYTHEMIA VERA - A CLINICAL EXPERIMENT
    LIMARZI, LR
    PAUL, JT
    SEED, L
    JOURNAL OF LABORATORY AND CLINICAL MEDICINE, 1952, 40 (06): : 919 - 919
  • [39] RUXOLITINIB VERSUS BEST AVAILABLE THERAPY IN PATIENTS WITH POLYCYTHEMIA VERA: 80-WEEK FOLLOW-UP FROM THE RESPONSE TRIAL
    Kiladjian, J. -J.
    Vannucchi, A. M.
    Griesshammer, M.
    Masszi, T.
    Durrant, S.
    Passamonti, F.
    Harrison, C. N.
    Pane, F.
    Zachee, P.
    Kirito, K.
    Cazzola, M.
    Besses, C.
    Blau, I.
    Mesa, R.
    Jones, M. M.
    He, S.
    Zhen, H.
    Li, J.
    Francillard, N.
    Habr, D.
    Verstovsek, S.
    HAEMATOLOGICA, 2015, 100 : 161 - 161
  • [40] Didanosine plus stavudine with or without hydroxyurea in HIV-1-infected patients: 1 year follow-up
    Rutschmann, OT
    Opravil, M
    Iten, M
    Malinverni, R
    Vernazza, PL
    Bucher, H
    Bernasconi, E
    Perrin, LH
    Yerly, S
    Hirschel, B
    ANTIVIRAL THERAPY, 1998, 3 : 65 - 67
12345